Purpose

This study aims to comprehensively delineate the phenotypic spectrum of ACTL6B-related disorders, previously associated with both autosomal recessive and autosomal dominant neurodevelopmental disorders. Molecularly, the role of the nucleolar protein ACTL6B in contributing to the disease has remained unclear.
Methods
We identified 105 affected individuals, including 39 previously reported cases, and systematically analyzed detailed clinical and genetic data for all individuals. Additionally, we conducted knockdown experiments in neuronal cells to investigate the role of ACTL6B in ribosome biogenesis.

Results

Biallelic variants in ACTL6B are associated with severe-to-profound global developmental delay/intellectual disability, infantile intractable seizures, absent speech, autistic features, dystonia, and increased lethality. De novo monoallelic variants result in moderate-to-severe global developmental delay/intellectual disability, absent speech, and autistic features, whereas seizures and dystonia were less frequently observed. Dysmorphic facial features and brain abnormalities, including hypoplastic corpus callosum, and parenchymal volume loss/atrophy, are common findings in both groups. We reveal that in the nucleolus, ACTL6B plays a crucial role in ribosome biogenesis, particularly in pre-rRNA processing.

Conclusion

This study provides a comprehensive characterization of the clinical spectrum of both autosomal recessive and dominant forms of ACTL6B-associated disorders. It offers a comparative analysis of their respective phenotypes provides a plausible molecular explanation and suggests their inclusion within the expanding category of “ribosomopathies.”

1. Olave, I., Wang, W., Xue, Y., Kuo, A., & Crabtree, G. R. (2002). Identification of a polymorphic, neuron-specific chromatin remodeling complex. Genes & Development, 16(19), 2509–2517. https://doi.org/10.1101/gad.1017102
2. Wu, J. I., Lessard, J., Olave, I. A., Qiu, Z., Ghosh, A., Graef, I. A., & Crabtree, G. R. (2007). Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron, 56(1), 94–108. https://doi.org/10.1016/j.neuron.2007.08.021
3. Lessard, J., Wu, J. I., Ranish, J. A., Wan, M., Winslow, M. M., Staahl, B. T., Wu, H., Aebersold, R., Graef, I. A., & Crabtree, G. R. (2007). An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron, 55(2), 201–215. https://doi.org/10.1016/j.neuron.2007.06.025
4. Sokpor, G., Xie, Y., Rosenbusch, J., & Tuoc, T. (2017). Chromatin remodeling BAF (SWI/SNF) complexes in neural development and disorders. Frontiers in Molecular Neuroscience, 10, Article 243. https://doi.org/10.3389/fnmol.2017.00243
5. Bell, S., Rousseau, J., Peng, H., Han, H., Ribeiro-dos-Santos, A. M., Wu, H., Stegeman, S., Qiao, Y., Zeng, B. P., Hou, M. Y., Tan, W. H., Bennett, J. T., McCartin, M., Reilly, J., Grompe, M., Zarate, Y. A., Phadke, R., Rosenfeld, J. A., ... & Campeau, P. M. (2019). Mutations in ACTL6B cause neurodevelopmental deficits and epilepsy and lead to loss of dendrites in human neurons. American Journal of Human Genetics, 104(5), 815–834. https://doi.org/10.1016/j.ajhg.2019.03.022
6. Sekiguchi, F., Tsurusaki, Y., Okamoto, N., Teik, K. W., Mizuno, S., Suzumura, H., Isidor, B., Bilan, F., Leheup, B., Tanaka, R., Hamada, J., King, S., Mook, O. R., Matsumoto, N., Saitsu, H., & Miyake, N. (2019). Genetic abnormalities in a large cohort of Coffin–Siris syndrome patients. Journal of Human Genetics, 64(12), 1173–1186. https://doi.org/10.1038/s10038-019-0667-4
7. Santen, G. W. E., Aten, E., Vulto-van Silfhout, A. T., Pottinger, C., van Bon, B. W., van Haeringen, A., Twigg, S. R., Manchester, D. K., Kim, C. A., Natacci, F., Brancati, F., Di-Donato, N., Reis, A., Wieczorek, D., Gillessen-Kaesbach, G., Rauch, A., Lessel, D., ... & CSS Consortium. (2013). Coffin–Siris syndrome and the BAF complex: Genotype–phenotype study in 63 patients. Human Mutation, 34(11), 1519–1528. https://doi.org/10.1002/humu.22420
8. Chen, C. A., Lattier, J., Zhu, W., Stankiewicz, P., Liu, P., Bi, W., Lupski, J. R., & Xiao, R. (2022). Retrospective analysis of a clinical exome sequencing cohort reveals the mutational spectrum and identifies candidate disease-associated loci for BAFopathies. Genetics in Medicine, 24(2), 364–373. https://doi.org/10.1016/j.gim.2021.09.014
9. Cappuccio, G., Sayou, C., Tanno, P. L., Smit, J. D. E., Pagnamenta, A. T., ... & The RADO Group. (2020). De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides-Baraitser syndrome. Genetics in Medicine, 22(11), 1838–1850. https://doi.org/10.1038/s41436-020-0906-x
10. Abdul-Rahman, O. (2015). Nicolaides-Baraitser syndrome. In M. P. Adam, G. M. Mirzaa, & R. A. Pagon (Eds.), GeneReviews. University of Washington, Seattle. https://www.ncbi.nlm.nih.gov/books/NBK321516/
11. Peron, A., Bradbury, K., & Viskochil, D. H. (2019). BCL11A-related intellectual disability. In M. P. Adam, G. M. Mirzaa, & R. A. Pagon (Eds.), GeneReviews. University of Washington, Seattle. https://www.ncbi.nlm.nih.gov/books/NBK547048/
12. Lessel, D., Gehbauer, C., Bramswig, N. C., ... & Kubisch, C. (2018). BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain, 141(8), 2299–2311. https://doi.org/10.1093/brain/awy173
13. Fichera, M., Failla, P., Saccuzzo, L., Mattina, T., Arrigo, P., Salvo, E., Castiglia, L., Di Benedictis, L., & Romano, C. (2019). Mutations in ACTL6B, coding for a subunit of the neuron-specific chromatin remodeling complex nBAF, cause early onset severe developmental and epileptic encephalopathy with brain hypomyelination and cerebellar atrophy. Human Genetics, 138(2), 187–198. https://doi.org/10.1007/s00439-019-01977-w
14. Maddirevula, S., Alzahrani, F., Al-Owain, M., ... & Alkuraya, F. S. (2019). Autozygome and high throughput confirmation of disease genes candidacy. Genetics in Medicine, 21(3), 736–742. https://doi.org/10.1038/s41436-018-0138-x
15. Yüksel, Z., Yazol, M., & Gümüş, E. (2019). Pathogenic homozygous variations in ACTL6B cause DECAM syndrome: Developmental delay, epileptic encephalopathy, cerebral atrophy, and abnormal myelination. American Journal of Medical Genetics Part A, 179(8), 1603–1608. https://doi.org/10.1002/ajmg.a.61204
16. Wenderski, W., Wang, L., Krokhotin, A., ... & Lasisi, A. (2020). Loss of the neural-specific BAF subunit ACTL6B relieves repression of early response genes and causes recessive autism. Proceedings of the National Academy of Sciences, 117(18), 10055–10066. https://doi.org/10.1073/pnas.1918283117
17. Han, X., Deng, J., Chen, C., & Wang, Q. (2022). Developmental and epileptic encephalopathy 76: Case report and review of literature. Children, 9(12), Article 1967. https://doi.org/10.3390/children9121967
18. Stenström, L., Mahdessian, D., Gnann, C., ... & Lundberg, E. (2020). Mapping the nucleolar proteome reveals a spatiotemporal organization related to intrinsic protein disorder. Molecular Systems Biology, 16(8), Article e9469. https://doi.org/10.15252/msb.20209469
19. Hetman, M., & Slomnicki, L. P. (2019). Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies. Journal of Neurochemistry, 148(3), 325–347. https://doi.org/10.1111/jnc.14576
20. Sobreira, N., Schiettecatte, F., Valle, D., & Hamosh, A. (2015). GeneMatcher: A matching tool for connecting investigators with an interest in the same gene. Human Mutation, 36(10), 928–930. https://doi.org/10.1002/humu.22844
21. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., ... & Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2
22. Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010). Features and development of Coot. Acta Crystallographica Section D: Biological Crystallography, 66(4), 486–501. https://doi.org/10.1107/S090744491000749X
23. Abramoff, M. D., Magalhaes, P. J., & Ram, S. J. (2004). Image processing with ImageJ. Biophotonics International, 11(7), 36–42.
24. Hodgkinson, A., & Eyre-Walker, A. (2011). Variation in the mutation rate across mammalian genomes. Nature Reviews Genetics, 12(11), 756–766. https://doi.org/10.1038/nrg3098
25. Mullineux, S. T., & Lafontaine, D. L. J. (2012). Mapping the cleavage sites on mammalian pre-rRNAs: Where do we stand? Biochimie, 94(7), 1521–1532. https://doi.org/10.1016/j.biochi.2012.02.001
26. Farley-Barnes, K. I., Ogawa, L. M., & Baserga, S. J. (2019). Ribosomopathies: Old concepts, new controversies. Trends in Genetics, 35(10), 754–767. https://doi.org/10.1016/j.tig.2019.07.004
27. Delhermite, J., Tafforeau, L., Sharma, S., ... & Lafontaine, D. L. J. (2022). Systematic mapping of rRNA 2′-O methylation during frog development and involvement of the methyltransferase fibrillarin in eye and craniofacial development in Xenopus laevis. PLoS Genetics, 18(1), Article e1010012. https://doi.org/10.1371/journal.pgen.1010012
28. Dixon, J., Jones, N. C., Sandell, L. L., Jayasinghe, S. M., Crane, J., Reyna-Neyra, A., ... & Dixon, M. J. (2006). Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proceedings of the National Academy of Sciences, 103(36), 13403–13408. https://doi.org/10.1073/pnas.0605630103
29. van Tran, N., Ernst, F. G. M., Hawley, B. R., ... & Motorin, Y. (2019). The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Research, 47(15), 7719–7733. https://doi.org/10.1093/nar/gkz619
30. Richard, E. M., Polla, D. L., Assir, M. Z., ... & Riazuddin, S. (2019). Bi-allelic variants in METTL5 cause autosomal-recessive intellectual disability and microcephaly. American Journal of Human Genetics, 105(4), 869–878. https://doi.org/10.1016/j.ajhg.2019.09.007
31. Leismann, J., Spagnuolo, M., Pradhan, M., ... & Roignant, J. Y. (2020). The 18S ribosomal RNA m6A methyltransferase Mettl5 is required for normal walking behavior in Drosophila. EMBO Reports, 21(7), Article e49443. https://doi.org/10.15252/embr.201949443
32. Wang, L., Liang, Y., Lin, R., ... & Cheng, Y. (2022). Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function. Genes & Diseases, 9(1), 268–274. https://doi.org/10.1016/j.gendis.2020.10.005
33. Valencia, A. M., Sankar, A., van der Sluijs, P. J., ... & mSWI/SNF NDD Consortium. (2023). Landscape of mSWI/SNF chromatin remodeling complex perturbations in neurodevelopmental disorders. Nature Genetics, 55(8), 1400–1412. https://doi.org/10.1038/s41588-023-01449-x